HEC88473

· Dongguan HEC Biopharmaceutical R&D Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HEC88473, covering 2025-04-29 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus [Phase 2]